Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Pommier

Showing results (231-240 of 251) with videos related to

Pageof 26
Sort By:
Current Cancer Drug Targets|August 13, 2011
RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitorsS E Martin, Z-H Wu, K Gehlhaus, et al.
Journal of Medicinal Chemistry|June 21, 1996
Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and proteaseA Mazumder, S Wang, N Neamati, et al.
Bioorganic & Medicinal Chemistry|November 1, 2000
Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targetsI J Chen, N Neamati, M C Nicklaus, et al.
Molecular Pharmacology|August 23, 2000
Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl estersW Pluymers, N Neamati, C Pannecouque, et al.
Oncogene|January 13, 2006
p21CDKN1A allows the repair of replication-mediated DNA double-strand breaks induced by topoisomerase I and is inactivated by the checkpoint kinase inhibitor 7-hydroxystaurosporineT Furuta, R L Hayward, L-H Meng, et al.
Journal of Medicinal Chemistry|August 14, 1998
Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active siteN Neamati, H Hong, J M Owen, et al.
Blood|January 15, 1998
Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridolB W Parker, G Kaur, W Nieves-Neira, et al.
Molecular Cancer Therapeutics|December 7, 2002
Dual role of glutathione in modulating camptothecin activity: depletion potentiates activity, but conjugation enhances the stability of the topoisomerase I-DNA cleavage complexM P Gamcsik, M S Kasibhatla, D J Adams, et al.
Molecular Pharmacology|April 1, 1997
Probing interactions between viral DNA and human immunodeficiency virus type 1 integrase using dinucleotidesA Mazumder, H Uchida, N Neamati, et al.
Nature Medicine|August 2, 2001
Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repairY Takebayashi, P Pourquier, D B Zimonjic, et al.
Pageof 26

Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
Current Cancer Drug Targets|August 13, 2011
RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitorsS E Martin, Z-H Wu, K Gehlhaus, et al.
Journal of Medicinal Chemistry|June 21, 1996
Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and proteaseA Mazumder, S Wang, N Neamati, et al.
Bioorganic & Medicinal Chemistry|November 1, 2000
Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targetsI J Chen, N Neamati, M C Nicklaus, et al.
Molecular Pharmacology|August 23, 2000
Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl estersW Pluymers, N Neamati, C Pannecouque, et al.
Oncogene|January 13, 2006
p21CDKN1A allows the repair of replication-mediated DNA double-strand breaks induced by topoisomerase I and is inactivated by the checkpoint kinase inhibitor 7-hydroxystaurosporineT Furuta, R L Hayward, L-H Meng, et al.
Journal of Medicinal Chemistry|August 14, 1998
Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active siteN Neamati, H Hong, J M Owen, et al.
Blood|January 15, 1998
Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridolB W Parker, G Kaur, W Nieves-Neira, et al.
Molecular Cancer Therapeutics|December 7, 2002
Dual role of glutathione in modulating camptothecin activity: depletion potentiates activity, but conjugation enhances the stability of the topoisomerase I-DNA cleavage complexM P Gamcsik, M S Kasibhatla, D J Adams, et al.
Molecular Pharmacology|April 1, 1997
Probing interactions between viral DNA and human immunodeficiency virus type 1 integrase using dinucleotidesA Mazumder, H Uchida, N Neamati, et al.
Nature Medicine|August 2, 2001
Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repairY Takebayashi, P Pourquier, D B Zimonjic, et al.
Pageof 26